New rivals to top diabetes drug Lantus show promise in studies

13:00 EDT 14 Jun 2014 | Reuters

June 14 (Reuters) - Diabetes patients stand to benefit from two experimental insulin therapies that could eventually replace Sanofi's global leader Lantus, according to results from large clinical trials released on Saturday.

Original Article: New rivals to top diabetes drug Lantus show promise in studies

NEXT ARTICLE

More From BioPortfolio on "New rivals to top diabetes drug Lantus show promise in studies"

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement

Searches Linking to this Story